Intention notice: Reagents for genotyping dihydropyrimidin dehydrogenase (DPYD) and reagents/kits for gene analyses for Helse Bergen HF

d by the Cancer Genetics Department at Haukeland University Hospital. Current agreements expire and Helse Bergen therefore needs new contracts that come into force when current agreements expire. The company merges the current contracts into one contract when a new framework agreement is signed. Th

e reagents must be compatible with the LC480 II instrument procured in 2021. Necessary reagents that are compatible with the existing equipment and method can only be procured by Triolab AS, and on this basis a competition cannot be arrange